Efficacy of rikkosan for primary burning mouth syndrome: a retrospective study

Hato, Hiroyuki; Sakata, Ken-ichiro; Sato, Jun; Asaka, Takuya; Ohga, Noritaka; Yamazaki, Yutaka; Kitagawa, Yoshimasa

Efficacy of rikkosan for primary burning mouth syndrome: a retrospective study

Hato, Hiroyuki; Sakata, Ken-ichiro; Sato, Jun et al.

BioPsychoSocial Medicine, 2021, 15(1), 19

Permalink : https://hdl.handle.net/2115/83412

このアイテムのアクセス数:521件（2026-08-17 03:51 集計）

閲覧可能ファイル

ファイル	フォーマット	サイズ	閲覧回数	説明
https://doi.org/10.1186/s13030-021-00221-2			11

論文情報

ファイル出力 EndNote Basic出力 Mendeley出力

アクセス権	open access
URI	https://hdl.handle.net/2115/83412
タイトル	Efficacy of rikkosan for primary burning mouth syndrome: a retrospective study
著者	Hato, Hiroyuki ; Sakata, Ken-ichiro ; Sato, Jun ; Asaka, Takuya ; Ohga, Noritaka ; Yamazaki, Yutaka ; Kitagawa, Yoshimasa
著者名 Hato, Hiroyuki
e-Rad_Researcher 10826051 著者名 Sakata, Ken-ichiro
e-Rad_Researcher 60319069 著者名 Sato, Jun
e-Rad_Researcher 80637265 著者名 Asaka, Takuya
e-Rad_Researcher 40548202 著者名 Ohga, Noritaka
e-Rad_Researcher 90250464 著者名 Yamazaki, Yutaka
e-Rad_Researcher 00224957 著者名 Kitagawa, Yoshimasa
言語	英語
キーワード	Burning mouth syndrome
	Pharmacotherapy
	Kampo medicine
発行日	2021-10-30
出版者	BioMed Central
収録物名	BioPsychoSocial Medicine
巻(号)	15(1)
ページ	19
抄録	Background Burning mouth syndrome (BMS) is a chronic condition characterized by pain in the oral cavity. Kampo medicine is a traditional Japanese medical system that has its roots partly in ancient Chinese medicine. The purpose of this study is to evaluate the efficacy of rikkosan-a traditional Japanese herbal medicine (Kampo)-in the treatment of primary BMS. Main body A single-center retrospective study was conducted in 32 patients who were diagnosed with primary BMS and treated with rikkosan alone through gargling (2.5 g rikkosan dissolved in 50 mL hot water) three times daily. Patients were asked to evaluate their pain using a numerical rating scale (NRS) at first visit and after 1 month. One patient had stomatitis as a side effect after gargling with rikkosan, however, no side effects were observed in other patients. Overall NRS scores decreased significantly between the first visit (7.6 +/- 2.7) and the 1-month visit (5.6 +/- 2.8). Conclusions Rikkosan may be an effective treatment for primary BMS.
資源タイプ	学術雑誌論文
出版タイプ	Version of Record
PISSN	1751-0759
関連情報	PMID 34717696
関連情報 (isIdenticalTo)	出版社版DOI https://doi.org/10.1186/s13030-021-00221-2